Aim Differentiated thyroid cancer (DTC) in children and adolescents is rare and data about
its presentation and management are not well known. The aim of this study was to provide …

Aims To obtain an overview of the management and outcomes of children aged 18 years or
younger diagnosed with differentiated thyroid carcinoma of follicular cell origin across the …

Introduction: Treatment for differentiated thyroid carcinoma (DTC) in pediatric patients is
based mainly on evidence from adult series due to lack of data from pediatric cohorts. Our …

Background: Thyroid gland malignancies are rare in pediatric patients (0.7% of tumors); only
1.8% are observed in patients aged< 20 years, with a higher prevalence recorded in women …

Thyroid tumors affect all age groups, including children and adolescents. Malignant cancer
of the thyroid is a relatively uncommon disease in pediatric age. In the recent decades the …

Purpose To describe the clinical features of a paediatric cohort affected by differentiated
thyroid cancer (DTC) followed in a tertiary Department of Paediatric Endocrinology. Methods …

Follicular cell-derived thyroid cancer is far less common in children than adults and accounts
for approximately 1% of all pediatric malignancies. Compared with adults, children and …

Introduction Pediatric thyroid carcinoma is a rare malignancy and data on long-term
oncological outcomes are sparse. The aim of this study was to describe the long-term …

Abstract Background/Purpose The purpose of the study is to describe the anatomoclinical,
diagnostic, therapeutic and prognostic aspects of pediatric follicular thyroid carcinoma (FTC) …

Although with a standardized incidence of 0.54 cases per 100,000 persons, differentiated
thyroid cancer (DTC) is a rare disease in children and adolescents, it nonetheless …